Can I invite comment as to a possible sale of the infusion business with a loss of ?$.5m profit per quarter but with a sale price of ?$8mbeing available in our survival mode.
What i would really like to know are the figures for an Adapt only company i.e. $3.1m in this quarter but what are the costs to get these sales.
If the loss was $5m per quarter i could see some light with future increase in sales. The infusion business generates nearly $2m in profits per annum but the cost to do so is $14m. Take this out of the equation and where do we stand. To survive I would be willing to sell the infusions and 75% of the TAVR.
Ann: Appendix 4C - quarterly, page-34
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |